Please upgrade your browser.
The study has revealed that usually the kidney cancer patients needing surgery have their whole kidney taken out but the patients can healthily survive long-term even if just a part of the organ is removed.
The goal of this clinical research study is to learn if SutentÂ® (sunitinib malate), given before surgery, can help control renal cell carcinoma. The safety of sunitinib malate will also be studied.
This phase I trial is studying the side effects and best dose of interleukin-7 in treating patients with metastatic melanoma or locally advanced or metastatic kidney cancer.
Meet other families that are dealing with renal cancers at www.KidneyCancer.ME
...even under optimum conditions, people suffering from afflictions such as heart disease and cancer will face more than a five-and-a-half month wait before getting the treatment they need.
One third of patients with kidney cancer are diagnosed in the metastatic stage, and among patients with a localized form, about 30 to 40% will develop metastases after surgery.
Tinzaparin may stop the growth of kidney cancer by blocking blood flow to the tumor.
Such excess risk, however, might be due to exposure to phenacetin-containing analgesics, which have been reported to increase renal cell cancer risk.
Despite economic malaise and a crush of negative publicity about their university during the past four months, Penn State students raised a record $10.69 million to support families of children with cancer.
Winners were selected in the Kidney Cancer Association's "Lunch Date With Denise Richards Contest."
|Powered by NeonCRM|